Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 601-147-9 | CAS number: 111988-49-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24 Feb - 21 Mar 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- adopted 2016
- Deviations:
- yes
- Remarks:
- intraperitoneal injection not recommended as exposure route.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- adopted 1983
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 3-(2-chlor-5-pyridyl-methyl)-cyanimino-1,3-thiazolidin
- EC Number:
- 601-147-9
- Cas Number:
- 111988-49-9
- Molecular formula:
- C10H9ClN4S
- IUPAC Name:
- 3-(2-chlor-5-pyridyl-methyl)-cyanimino-1,3-thiazolidin
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Borchen, Germany
- Age at study initiation: 6 - 12 weeks
- Weight at study initiation: 27 - 43 g
- Assigned to test groups randomly: yes
- Housing: singly in type I cages with bedding of soft wood granules, type S 8/15
- Diet: Altromin 1324 Standard Diet (Altromin GmbH, lage, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 1.5
- Humidity (%): 40 - 70
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- 0.5 % aqueous Cremophor emulsion
- Details on exposure:
- Preparation of dosing solutions:
The test substance was suspended in 0.5 % aqueous Cremophor emulsion, using sonication for 30 minutes. The substance was injected intraperitoneally. The administered volume was 10 mL/kg bw. The same conditions were used for the positive control substance cyclophosphamide that was dissolved in deionized water. - Duration of treatment / exposure:
- single injection
- Frequency of treatment:
- once
- Post exposure period:
- Test substance: 16, 24, 48 h
Control animals: 24 h
Positive control: 24 h
Doses / concentrations
- Dose / conc.:
- 60 mg/kg bw (total dose)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide
- Justification for choice of positive control(s): proven cytostatic agent and known clastogen
- Route of administration: injected intraperitoneally
- Doses / concentrations: 20 mg/kg bw
Examinations
- Tissues and cell types examined:
- bone marrow cells
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
The doses were based on a pre-test in which groups of five animals received the test substance intraperitoneally at 10, 50, 75 and 100 mg/kg bw. For up to one hour, apathy, reduced motility, spasm, twitching, shivering and difficulty in breathing was observed in animals receiving 50 mg/kg bw or higher. In addition, 1 of 5 and 5 of 5 animals died in the 75 and 100 mg/kg bw groups, respectively. Therefore, the test substance was administered at a dose level of 60 mg/kg bw in the main test.
TREATMENT AND SAMPLING TIMES:
After the designated time, animals were sacrificed. At least one intact femur was prepared from each sacrificed animal (not pretreated with a spindle inhibitor). The bone marrow was flushed out with fetal calf serum. The serum-bone marrow suspension was centrifuged and most of the supernatant discarded. The pellet was resuspended in the remaining liquid to produce a homogeneous suspension.
DETAILS OF SLIDE PREPARATION:
One drop of the viscous suspension was placed on a well-cleaned slide and spread to allow proper evaluation of the smear. The slides were dried overnight and stained automatically with an Ames Hema- Tek Slide Stainer (Miles Company). The slides were then "destained" with methanol, rinsed with deionized water, and left to dry.
METHOD OF ANALYSIS:
Micronuclei were analyzed with a light microscope at a magnification of about 1000. 1000 polychromatic erythrocytes were counted per animal. The number of normochromatic erythrocytes per 1000 polychromatic ones was noted. Additionally, the number of normochromatic erythrocytes showing micronuclei was assessed. - Evaluation criteria:
- A test was considered positive if there was a relevant and significant increase in the number of polychromatic erythrocytes showing micronuclei in comparison to the negative control at any of the time intervals investigated.
A test was considered negative if there was no relevant or significant increase in the rate of micronucleated polychromatic erythrocytes at any time. A test was also considered negative if there was a significant increase in that rate which, according to the laboratory's experience was within the range of negative controls.
A test was considered equivocal if there was an increase of micronucleated polychromatic erythrocytes above the range of attached historical negative controls, provided the increase was not significant and the result of the negative control was not closely related to the data of the respective treatment group.
Acceptability
A test was considered acceptable if the solvent and positive control fall withing the expected range, in accordance with the laboratory's experience and/or the available literature data - Statistics:
- When the negative control mean was superceded by any group, the test group with the highest mean and the positive control were checked by Wilcoxon's non-parametric rank sum test with respect to the number of polychromatic erythrocytes having micronuclei and the number of normochromatic erythrocytes. Significance was set at p below 5%.
The rate of normochromatic erythrocytes containing micronuclei was examined if the micronuclear rate for polychromatic erythrocytes was already relevantly increased. In this case, the group with the highest mean was compared with the negative control using the one-sided Chi 2-test.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- mortality and clinical signs
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
The doses were based on a pre-test in which groups of five animals received the test substance intraperitoneally at 10, 50, 75 and 100 mg/kg bw. For up to one hour, apathy, reduced motility, spasm, twitching, shivering and difficulty in breathing was observed in animals receiving 50 mg/kg bw or higher. In addition, 1 of 5 and 5 of 5 animals died in the 75 and 100 mg/kg bw groups, respectively.
RESULTS OF DEFINITIVE STUDY
- Clinical signs: apathy, roughened fur, spasm and difficulty in breathing for up to 16 h after administration
- Mortality: 3/40 treated animals died during the test period
- Induction of micronuclei: no difference between control and treatment groups
- Ratio of PCE/NCE: no difference between control and treatment groups
- Positive control: the samples from the positive control had statistically significant increases in
the number of polychromatic erythrocytes compared with the concurrent control group which demonstrated that the test system was capable of detecting a known clastogen.
Summarized results can be found in Attachment 1.
- Historical control data: the negative and positive control are within the historical controls (refer to the attached background material 2).
Applicant's summary and conclusion
- Conclusions:
- The study was performed according to OECD guideline 474 dated 1983 and compliant with GLP. In the present bone marrow micronucleus assay, there was no evidence of clastogenicity or aneugenicity following an intraperitoneal injection of 60 mg/kg bw of the test item, in both male and female mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.